Jul 29 (Reuters)-
Genky Drugstores Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 20, 2024 Jun 20, 2023 Jun 20, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 184.86 169.06 202.00 100.00
(+9.3 pct) (+9.3 pct) (+9.3 pct) (+8.7 pct)
Operating 9.02 6.71 10.00 5.00
(+34.4 pct) (+18.2 pct) (+10.9 pct) (+14.0 pct)
Recurring 9.27 7.08 10.22 5.11
(+30.9 pct) (+16.3 pct) (+10.3 pct) (+13.7 pct)
Net
Net 6.32 4.76 7.00 3.50
(+32.7 pct) (+7.8 pct) (+10.7 pct) (+13.3 pct)
EPS 208.21 yen 156.92 yen 230.39 yen 115.19 yen
EPS Diluted 207.94 yen 156.79 yen
Ann Div 25.50 yen 25.00 yen 13.00 yen
-Q2 Div 12.50 yen 12.50 yen 6.50 yen
-Q4 Div 13.00 yen 12.50 yen 6.50 yen
NOTE - Genky Drugstores Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9267.T